AMN on NYSE
AMN HEALTHCARE SERVICES INC
AMN HEALTHCARE SERVICES INC is an American help supply services company based in San Diego, listed on NYSE (AMN).2
Price unavailable
Last updated Oct 21, 2026.
Overview
Compare with TTEC, Everforth Inc or Kelly Services, or pick any stock.
- TickerAMN on NYSE2
- IndustryServices-Help Supply Services2
- HeadquartersSan Diego, United States2
- Incorporated inDE3
- Business address2999 Olympus Boulevard, Suite 500, Dallas, Tx 750193
- Filer categoryLarge accelerated filer3
- Legal formCorporation2
- LEI529900W3ARRTCNFH2I392
- StatusActive2
- LEI statusLapsed (not renewed)2
- Registered addressc/o CORPORATION SERVICE COMPANY, 251 LITTLE FALLS DRIVE, 19808 Wilmington, United States2
- Registered withDivision of Corporations, Department of State, 28195822
See how the biggest companies compare on our leaderboards
AMN Healthcare empowers the future of care through one of the nation’s broadest network of highly-qualified healthcare professionals. As the leader and innovator in total talent solutions for the healthcare sector in the United States, we tailor our solutions to our clients’ workforce challenges and goals, and provide staffing, talent optimization strategies, and technology solutions to support caregivers and patient care. We are passionate about all aspects of our mission to:5 From its latest annual report
Financials
From the company’s reports to the SEC. Every number links to the filing it came from.
Key numbers, fiscal 2025
28.3%Gross margin6
-2.0%Operating margin6
-3.5%Net margin6
-8.5%Revenue growth, 20256
-14.9%Return on equity6
1.19×Debt to equity6
$233.8MFree cash flow6
What sells
Revenue by product, business segment and region, as the company reports it to the SEC.
Products and services
Allied Staffing brought in 23% of the revenue AMN HEALTHCARE SERVICES INC broke down this way in fiscal 2025.
Products and services by year
| Products and services | 2023 | 2024 | 2025 |
|---|---|---|---|
| Allied Staffing | $709.6M | $610.7M | $582.3M |
| Locum Tenens Staffing | $464.8M | $566.4M | $565.2M |
| Technology-enabled Services | $449.7M | $421.0M | $375.9M |
| Language Services | $260.1M | $298.2M | $295.5M |
| Labor Disruption Services | $13.3M | $63.3M | $191.2M |
| International Nurse | $226.5M | $177.7M | $129.1M |
| International Nurse Staffing | $208.1M | $165.9M | $119.8M |
| Interim Leadership Staffing | $137.0M | $115.7M | $93.9M |
| Vendor Management Systems | $169.4M | $104.3M | $71.7M |
| Permanent Placement | $86.3M | $58.4M | $46.6M |
| Local Staffing | $76.6M | $45.5M | $36.8M |
| Talent Planning and Acquisition | $45.3M | $18.4M | $10.9M |
Business segments
Nurse and Allied Healthcare Staffing brought in 60% of the revenue AMN HEALTHCARE SERVICES INC broke down this way in fiscal 2025.
Business segments by year
| Business segments | 2023 | 2024 | 2025 |
|---|---|---|---|
| Nurse and Allied Healthcare Staffing | $2.6B | $1.8B | $1.6B |
| Physician and Leadership Solutions | $669.7M | $728.6M | $696.4M |
| Technology And Workforce Solutions | $495.0M | $439.5M | $386.7M |
Where the money goes
Where each dollar of revenue went, fiscal 2025
- Cost of revenue72¢$2.0B
- Selling, general and admin22¢$593.0M
- Other costs6¢$175.7M
- Income tax0¢$5.4M
Out of $2.7B in revenue.6 The company lost money this year.
Where each dollar of operating cash went, fiscal 2025
- Capital spending13¢$35.6M
- Kept or used elsewhere87¢$233.8M
Out of $269.5M of cash from operations.6
Financial statements
Every line of the income statement as filed: the last 3 fiscal years, latest first.6
| Period ending | 2025-12-31 | 2024-12-31 | 2023-12-31 |
|---|---|---|---|
| Revenue | $2.7B | $3.0B | $3.8B |
| Cost of revenue | $2.0B | $2.1B | $2.5B |
| Gross profit | $774.1M | $919.4M | $1.2B |
| Selling, general and administrative | $593.0M | $632.5M | $748.4M |
| Depreciation and amortization (exclusive of depreciation included in cost of revenue) | $147.9M | $167.1M | $154.9M |
| Gain on sale of disposal group | -$39.1M | $0 | $0 |
| Goodwill impairment losses | $109.5M | $222.5M | $0 |
| Long-lived assets impairment losses | $18.3M | $0 | $7.8M |
| Total operating expenses | $829.5M | $1.0B | $911.2M |
| Income (loss) from operations | -$55.5M | -$102.7M | $338.4M |
| Interest expense, net, and other | $45.6M | $69.9M | $54.1M |
| Income (loss) before income taxes | -$101.1M | -$172.6M | $284.3M |
| Income tax expense (benefit) | -$5.4M | -$25.6M | $73.6M |
| Net income (loss) | -$95.7M | -$147.0M | $210.7M |
| Unrealized gains on available-for-sale securities, net, and other | $309.0K | $412.0K | $516.0K |
| Other comprehensive income | $309.0K | $412.0K | $516.0K |
| Comprehensive income (loss) | -$95.4M | -$146.6M | $211.2M |
| Basic (in dollars per share) | -$2.48 | -$3.85 | $5.38 |
| Diluted (in dollars per share) | -$2.48 | -$3.85 | $5.36 |
| Basic (in shares) | 38.5M shares | 38.2M shares | 39.2M shares |
| Diluted (in shares) | 38.5M shares | 38.2M shares | 39.3M shares |
No quarter-by-quarter statement was filed.
Every line of the balance sheet as filed: the last 4 fiscal years (annual) or 4 quarters (quarterly), latest first.6
| Period ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Cash and cash equivalents | $34.0M | $10.6M | ||
| Accounts receivable, net of allowances of $16,580 and $32,421 at December 31, 2025 and 2024, respectively | $382.6M | $437.8M | ||
| Accounts receivable, subcontractor | $48.0M | $70.5M | ||
| Prepaid expenses | $20.9M | $22.5M | ||
| Other current assets | $59.9M | $53.5M | ||
| Total current assets | $545.4M | $594.9M | ||
| Restricted cash, cash equivalents and investments | $45.6M | $71.8M | ||
| Fixed assets, net of accumulated depreciation of $414,797 and $360,795 at December 31, 2025 and 2024, respectively | $136.4M | $186.3M | ||
| Other assets | $282.6M | $258.1M | ||
| Deferred income taxes, net | $44.9M | $25.8M | ||
| Goodwill | $755.8M | $897.5M | $1.1B | |
| Intangible assets, net of accumulated amortization of $561,590 and $534,822 at December 31, 2025 and 2024, respectively | $283.5M | $381.4M | ||
| Total assets | $2.1B | $2.4B | ||
| Accounts payable and accrued expenses | $162.0M | $184.3M | ||
| Accrued compensation and benefits | $298.8M | $287.5M | ||
| Other current liabilities | $116.8M | $73.9M | ||
| Total current liabilities | $577.6M | $545.8M | ||
| Revolving credit facility | $25.0M | $210.0M | ||
| Notes payable, net of unamortized fees and premium | $742.1M | $845.9M | ||
| Other long-term liabilities | $107.3M | $107.5M | ||
| Total liabilities | $1.5B | $1.7B | ||
| Preferred stock, $0.01 par value; 10,000 shares authorized; none issued and outstanding at December 31, 2025 and 2024 | $0 | $0 | ||
| Common stock, $0.01 par value; 200,000 shares authorized; 51,054 issued and 38,441 outstanding at December 31, 2025 and 50,692 issued and 38,079 outstanding at December 31, 2024 | $511.0K | $507.0K | ||
| Additional paid-in capital | $559.3M | $528.5M | ||
| Treasury stock, at cost; 12,613 shares at December 31, 2025 and 2024 | -$1.1B | -$1.1B | ||
| Retained earnings | $1.2B | $1.3B | ||
| Accumulated other comprehensive income (loss) | $298.0K | -$11.0K | ||
| Total stockholders equity | $642.1M | $706.6M | $831.3M | $1.0B |
| Total liabilities and stockholders equity | $2.1B | $2.4B | ||
| Accounts receivable, allowance | $16.6M | $32.4M | ||
| Accumulated depreciation | $414.8M | $360.8M | ||
| Accumulated amortization | $561.6M | $534.8M | ||
| Preferred stock, par value (in dollars per share) | $0.01 | $0.01 | ||
| Preferred stock, shares authorized (in shares) | 10.0M shares | 10.0M shares | ||
| Preferred stock, shares issued (in shares) | 0 shares | 0 shares | ||
| Preferred stock, shares outstanding (in shares) | 0 shares | 0 shares | ||
| Common stock, par value (in dollars per share) | $0.01 | $0.01 | ||
| Common stock, shares authorized (in shares) | 200.0M shares | 200.0M shares | ||
| Common stock, shares issued (in shares) | 51.1M shares | 50.7M shares | ||
| Common stock, shares outstanding (in shares) | 38.4M shares | 38.1M shares | ||
| Treasury stock (in shares) | 12.6M shares | 12.6M shares |
| Period ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Cash and cash equivalents | $34.0M | $10.6M | ||
| Accounts receivable, net of allowances of $16,580 and $32,421 at December 31, 2025 and 2024, respectively | $382.6M | $437.8M | ||
| Accounts receivable, subcontractor | $48.0M | $70.5M | ||
| Prepaid expenses | $20.9M | $22.5M | ||
| Other current assets | $59.9M | $53.5M | ||
| Total current assets | $545.4M | $594.9M | ||
| Restricted cash, cash equivalents and investments | $45.6M | $71.8M | ||
| Fixed assets, net of accumulated depreciation of $414,797 and $360,795 at December 31, 2025 and 2024, respectively | $136.4M | $186.3M | ||
| Other assets | $282.6M | $258.1M | ||
| Deferred income taxes, net | $44.9M | $25.8M | ||
| Goodwill | $755.8M | $897.5M | $1.1B | |
| Intangible assets, net of accumulated amortization of $561,590 and $534,822 at December 31, 2025 and 2024, respectively | $283.5M | $381.4M | ||
| Total assets | $2.1B | $2.4B | ||
| Accounts payable and accrued expenses | $162.0M | $184.3M | ||
| Accrued compensation and benefits | $298.8M | $287.5M | ||
| Other current liabilities | $116.8M | $73.9M | ||
| Total current liabilities | $577.6M | $545.8M | ||
| Revolving credit facility | $25.0M | $210.0M | ||
| Notes payable, net of unamortized fees and premium | $742.1M | $845.9M | ||
| Other long-term liabilities | $107.3M | $107.5M | ||
| Total liabilities | $1.5B | $1.7B | ||
| Preferred stock, $0.01 par value; 10,000 shares authorized; none issued and outstanding at December 31, 2025 and 2024 | $0 | $0 | ||
| Common stock, $0.01 par value; 200,000 shares authorized; 51,054 issued and 38,441 outstanding at December 31, 2025 and 50,692 issued and 38,079 outstanding at December 31, 2024 | $511.0K | $507.0K | ||
| Additional paid-in capital | $559.3M | $528.5M | ||
| Treasury stock, at cost; 12,613 shares at December 31, 2025 and 2024 | -$1.1B | -$1.1B | ||
| Retained earnings | $1.2B | $1.3B | ||
| Accumulated other comprehensive income (loss) | $298.0K | -$11.0K | ||
| Total stockholders equity | $642.1M | $706.6M | $831.3M | $1.0B |
| Total liabilities and stockholders equity | $2.1B | $2.4B | ||
| Accounts receivable, allowance | $16.6M | $32.4M | ||
| Accumulated depreciation | $414.8M | $360.8M | ||
| Accumulated amortization | $561.6M | $534.8M | ||
| Preferred stock, par value (in dollars per share) | $0.01 | $0.01 | ||
| Preferred stock, shares authorized (in shares) | 10.0M shares | 10.0M shares | ||
| Preferred stock, shares issued (in shares) | 0 shares | 0 shares | ||
| Preferred stock, shares outstanding (in shares) | 0 shares | 0 shares | ||
| Common stock, par value (in dollars per share) | $0.01 | $0.01 | ||
| Common stock, shares authorized (in shares) | 200.0M shares | 200.0M shares | ||
| Common stock, shares issued (in shares) | 51.1M shares | 50.7M shares | ||
| Common stock, shares outstanding (in shares) | 38.4M shares | 38.1M shares | ||
| Treasury stock (in shares) | 12.6M shares | 12.6M shares |
Cash flow is reported year to date, not quarter by quarter, so there are no separate quarterly figures.
Every line of the cash flow as filed: the last 3 fiscal years, latest first.6
| Period ending | 2025-12-31 | 2024-12-31 | 2023-12-31 |
|---|---|---|---|
| Net income (loss) | -$95.7M | -$147.0M | $210.7M |
| Depreciation and amortization (inclusive of depreciation included in cost of revenue) | $156.6M | $173.8M | $160.9M |
| Non-cash interest expense and other | $2.6M | $11.9M | $8.8M |
| Write-off of fees on credit facilities and senior notes | $1.2M | $0 | $0 |
| Change in fair value of contingent consideration liabilities | $0 | $0 | $2.4M |
| Increase in allowance for credit losses and sales credits | $2.5M | $3.3M | $23.9M |
| Provision for deferred income taxes | -$19.5M | -$51.1M | -$12.9M |
| Share-based compensation | $30.7M | $23.3M | $18.0M |
| Net loss (gain) on deferred compensation balances | $2.3M | -$1.2M | $465.0K |
| Goodwill impairment losses | $109.5M | $222.5M | $0 |
| Loss on disposal or impairment of long-lived assets | $18.3M | $65.0K | $8.1M |
| Gain on sale of disposal group | -$39.1M | $0 | $0 |
| Net loss (gain) on investments in available-for-sale securities | -$106.0K | $200.0K | $302.0K |
| Non-cash lease expense | -$708.0K | -$1.2M | $1.6M |
| Accounts receivable | $49.1M | $176.2M | $70.0M |
| Accounts receivable, subcontractor | $22.4M | $47.2M | $151.0M |
| Income taxes receivable | $3.2M | -$4.0M | $3.8M |
| Prepaid expenses | $1.5M | -$2.0M | -$1.5M |
| Other current assets | -$3.0M | -$8.5M | $4.2M |
| Other assets | $4.9M | $87.0K | -$3.2M |
| Accounts payable and accrued expenses | -$20.6M | -$154.9M | -$183.5M |
| Accrued compensation and benefits | -$12.0M | -$11.3M | -$80.1M |
| Other liabilities | $49.5M | $44.4M | -$10.2M |
| Deferred revenue | $6.0M | -$1.3M | -$558.0K |
| Net cash provided by operating activities | $269.5M | $320.4M | $372.2M |
| Purchase and development of fixed assets | -$35.6M | -$80.9M | -$103.7M |
| Purchase of investments | -$36.1M | -$1.4M | $0 |
| Proceeds from sale and maturity of investments | $10.8M | $9.1M | $9.9M |
| Proceeds from sale of disposal group | $65.3M | $0 | $0 |
| Proceeds from sale of equity investment | $0 | $0 | $77.0K |
| Payments to fund deferred compensation plan | -$6.4M | -$8.4M | -$24.9M |
| Proceeds from settlements of company-owned life insurance policies | $6.4M | $0 | $0 |
| Cash paid for other intangibles | $0 | $0 | -$1.7M |
| Cash received for working capital settlement of prior year acquisition | $0 | $1.6M | $0 |
| Net cash provided by (used in) investing activities | $4.3M | -$79.9M | -$412.5M |
| Payments on revolving credit facility | -$315.0M | -$375.0M | -$355.0M |
| Proceeds from revolving credit facility | $130.0M | $125.0M | $815.0M |
| Proceeds from senior notes | $400.0M | $0 | $0 |
| Redemption of senior notes | -$500.0M | $0 | $0 |
| Payments on loans payable | $0 | $0 | -$300.0K |
| Repurchase of common stock | $0 | $0 | -$424.7M |
| Payment of excise tax on share repurchases | $0 | -$3.7M | $0 |
| Payment of financing costs | -$8.8M | -$973.0K | -$3.6M |
| Earn-out payments to settle contingent consideration liabilities for prior acquisitions | $0 | $0 | -$7.5M |
| Cash paid for shares withheld for taxes | -$2.1M | -$4.8M | -$13.1M |
| Net cash provided by (used in) financing activities | -$295.9M | -$259.4M | $10.7M |
| Net decrease in cash, cash equivalents and restricted cash | -$22.1M | -$19.0M | -$29.6M |
| Cash paid for amounts included in the measurement of operating lease liabilities | $9.4M | $10.4M | $9.3M |
| Cash paid for interest (net of $229, $606 and $1,229 capitalized in 2025, 2024 and 2023, respectively) | $45.1M | $61.0M | $48.1M |
| Cash paid for income taxes | $7.8M | $28.2M | $78.3M |
| Fair value of tangible assets acquired in acquisitions, net of cash and restricted cash received | $0 | $0 | $48.9M |
| Goodwill | $0 | $0 | $175.8M |
| Intangible assets | $0 | $0 | $92.0M |
| Liabilities assumed | $0 | $0 | -$24.5M |
| Net cash paid for acquisitions | $0 | $0 | $292.2M |
| Purchase of fixed assets recorded in accounts payable and accrued expenses | $1.5M | $3.2M | $8.1M |
| Excise tax payable on share repurchases | $0 | $0 | $3.7M |
| Right-of-use assets obtained in exchange for operating lease liabilities | $1.3M | $5.0M | $36.6M |
| Interest capitalized | $229.0K | $606.0K | $1.2M |
No quarter-by-quarter statement was filed.
Corporate structure
AMN HEALTHCARE SERVICES INC sits at the top of its group. 23 entities, 2 countries on record. Switch between the flow chart and the network, and select any entity to see its details.
Major holders of AMN HEALTHCARE SERVICES INC
- Morgan Stanley Filed SCHEDULE 13G on AMN HEALTHCARE SERVICES INC, latest Aug 13, 2026
- VANGUARD CAPITAL MANAGEMENT LLC Filed SCHEDULE 13G on AMN HEALTHCARE SERVICES INC, latest Apr 29, 2026
- VANGUARD GROUP INC Filed SCHEDULE 13G/A on AMN HEALTHCARE SERVICES INC, latest Mar 26, 2026 (5 filings since Feb 9, 2022)
- INTEGRATED CORE STRATEGIES (US) LLC Filed SCHEDULE 13G/A on AMN HEALTHCARE SERVICES INC, latest Feb 12, 2026 (2 filings since Nov 10, 2025)
- FMR LLC Filed SCHEDULE 13G/A on AMN HEALTHCARE SERVICES INC, latest Nov 5, 2025 (7 filings since Sep 10, 2024)
- BlackRock Filed SCHEDULE 13G/A on AMN HEALTHCARE SERVICES INC, latest Apr 30, 2025 (5 filings since Jan 28, 2022)
- Boston Partners Filed SC 13G/A on AMN HEALTHCARE SERVICES INC, latest Nov 14, 2024 (2 filings since Feb 13, 2024)
- AMN HEALTHCARE SERVICES INC San Diego, California, United States
- Advanced Medical Personnel Services, LLC Subsidiary · Delaware, United States
- AMN Allied Services, LLC Subsidiary · Delaware, United States
- AMN Healthcare Allied, Inc. Subsidiary · Texas, United States
- AMN Healthcare Interim Solutions, LLC Subsidiary · Delaware, United States
- AMN Healthcare Labor Disruption, Inc. Subsidiary · California, United States
- AMN Healthcare Language Services, Inc. Subsidiary · Delaware, United States
- AMN Healthcare Locum Tenens, Inc. Subsidiary · Delaware, United States
- AMN Healthcare Physician Permanent Placement, LLC Subsidiary · California, United States
- AMN Healthcare, Inc. Subsidiary · Nevada, United States
- AMN Leadership Solutions, Inc. Subsidiary · Delaware, United States
- AMN Services, LLC Subsidiary · North Carolina, United States
- AMN Staffing Services, LLC Subsidiary · Delaware, United States
- AMN Workforce Solutions, LLC Subsidiary · Delaware, United States
- B4Health, LLC Subsidiary · Maryland, United States
- Connetics Communications, LLC Subsidiary · California, United States
- Medefis, Inc. Subsidiary · Delaware, United States
- MSI Systems Corp. Subsidiary · Pennsylvania, United States
- Nursefinders, LLC Subsidiary · Texas, United States
- O’Grady-Peyton International (USA), Inc. Subsidiary · Massachusetts, United States
- ShiftWise, Inc. Subsidiary · Oregon, United States
- Spectrum Insurance Company, Inc. Subsidiary · Hawaii, United States
- Stratus Video Costa Rica, S.A. Subsidiary · Costa Rica
Built from parent and subsidiary links from GLEIF, the Global Legal Entity Identifier Foundation (CC0); subsidiaries listed in Exhibit 21 of annual reports filed with the SEC; major holders from Schedules 13D and 13G. Each entity in the chart links to its source.
What it owns
What AMN HEALTHCARE SERVICES INC reports owning in its annual reports to the SEC: buildings, land and equipment, real estate and locations, investments, intangible assets and inventory, at the end of its latest fiscal year and a year before.
Property and equipment
| Item | Latest | A year before | Change |
|---|---|---|---|
| Furniture and fixtures | $97.9M6 Dec 31, 2025 | $91.0M6 Dec 31, 2024 | +7.6% |
| Computer equipment and software | $436.9M6 Dec 31, 2025 | $440.0M6 Dec 31, 2024 | −0.7% |
| Leasehold improvements | $16.4M6 Dec 31, 2025 | $16.1M6 Dec 31, 2024 | +2.0% |
| Property and equipment, before depreciation | $551.2M6 Dec 31, 2025 | $547.1M6 Dec 31, 2024 | +0.7% |
| Accumulated depreciation | $414.8M6 Dec 31, 2025 | $360.8M6 Dec 31, 2024 | +15.0% |
| Property and equipment, net | $136.4M6 Dec 31, 2025 | $186.3M6 Dec 31, 2024 | −26.8% |
| Operating-lease assets (leased space) | $27.0M6 Dec 31, 2025 | $32.1M6 Dec 31, 2024 | −15.8% |
Investments
| Item | Latest | A year before | Change |
|---|---|---|---|
| Cash and cash equivalents | $34.0M6 Dec 31, 2025 | $10.6M6 Dec 31, 2024 | +219.0% |
Intangibles and goodwill
| Item | Latest | A year before | Change |
|---|---|---|---|
| Goodwill | $755.8M6 Dec 31, 2025 | $897.5M6 Dec 31, 2024 | −15.8% |
| Intangible assets, net (excluding goodwill) | $283.5M6 Dec 31, 2025 | $381.4M6 Dec 31, 2024 | −25.7% |
| Finite-lived intangibles, gross | $845.1M6 Dec 31, 2025 | $916.2M6 Dec 31, 2024 | −7.8% |
| Accumulated amortization | $561.6M6 Dec 31, 2025 | $534.8M6 Dec 31, 2024 | +5.0% |
| Finite-lived intangibles, net | $283.5M6 Dec 31, 2025 | $381.4M6 Dec 31, 2024 | −25.7% |
Properties, in its own words
Location · Square Feet
Dallas, Texas (all segments) · 92,420
The rest of Item 2
San Diego, California (all segments) · 50,519
See additional information in “Item 8. Financial Statements and Supplementary Data—Notes to Consolidated Financial Statements—Note (6), Leases.”
Item 2 of the 10-K filed Feb 20, 2026.5
Leadership
Who has led AMN HEALTHCARE SERVICES INC, and when. Pick a name to see everywhere that person has worked.
Chief executive
Chief financial officer
Chief operating officer
2010201520202025
- Chief executive officerCaroline Grace Nov 30, 2022 to now14
- Chief executive officerSusan R. Salka Jan 5, 2006 to Sep 21, 202215
- ChairSteven C. Francis Apr 14, 2006 to Apr 11, 200816
- PresidentRalph Henderson Sep 6, 2007 to Jan 7, 201617
- PresidentSusan R. Salka Jan 5, 2006 to Feb 18, 202015
- Chief financial officerJeffrey R. Knudson Nov 2, 2021 to Nov 4, 202418
- Chief financial officerBrian M. Scott Jan 24, 2011 to Nov 2, 202119
- Chief financial officerBary Bailey Aug 10, 2009 to Nov 8, 201020
- Chief financial officerDavid C. Dreyer Apr 13, 2006 to Apr 14, 200921
- Chief operating officerBrian M. Scott Nov 21, 2024 to now22
- Chief operating officerSusan R. Salka Apr 5, 2006 to Apr 5, 200623
Board members and other officers (24)
- Interim Principal FinancialChristopher S. Schwartz Aug 18, 2021 to Aug 18, 202124
- Chief Information and DigitalMark Christopher Hagan Mar 18, 2020 to now25
- Pres., Prof. Svc. & StaffingRalph Henderson Feb 2, 2016 to Mar 5, 202026
- Board memberEric P. Palmer May 1, 2026 to now27
- Board memberCelia P. Huber May 2, 2025 to now28
- Board memberJim Hinton Jul 23, 2024 to now29
- Board memberCaroline Grace Nov 30, 2022 to now14
- Board memberJorge A. Caballero Dec 16, 2021 to now30
- Board memberSylvia Trent-Adams Oct 5, 2020 to now31
- Board memberTeri G. Fontenot Sep 17, 2019 to now32
- Board memberDaphne E. Jones Aug 9, 2018 to now33
- Board memberMark G. Foletta Dec 12, 2012 to now34
- Board memberWyche H. Walton Sep 3, 2010 to Apr 14, 201135
- Board memberMartha H. Marsh Sep 22, 2010 to Apr 23, 202436
- Board memberHala G. Moddelmog Feb 12, 2008 to May 18, 201037
- Board memberMichael M. E. Johns Dec 29, 2008 to Apr 23, 202138
- Board memberAndrew M. Stern Apr 20, 2007 to Apr 24, 202039
- Board memberSusan R. Salka Jan 5, 2006 to Sep 21, 202215
- Board memberDouglas D. Wheat Mar 17, 2006 to May 21, 202440
- Board memberR. Jeffrey Harris Apr 13, 2006 to now41
- Board memberKenneth F. Yontz May 4, 2006 to May 4, 200642
- Board memberPaul E. Weaver Jul 24, 2006 to Apr 19, 201943
- General counselWhitney M. Laughlin Sep 15, 2023 to now44
- General counselDenise L. Jackson Jan 31, 2006 to Aug 18, 202345
Subsidiaries and ownership
Subsidiaries (Exhibit 21)
- AMN Allied Services, LLC Delaware4
- AMN Healthcare Allied, Inc. Texas4
- AMN Healthcare Interim Solutions, LLC Delaware4
- AMN Healthcare Labor Disruption, Inc. California4
- AMN Healthcare Language Services, Inc. Delaware4
- AMN Healthcare Locum Tenens, Inc. Delaware4
- AMN Healthcare Physician Permanent Placement, LLC California4
- AMN Healthcare, Inc. Nevada4
- AMN Leadership Solutions, Inc. Delaware4
- AMN Services, LLC North Carolina4
- AMN Staffing Services, LLC Delaware4
- AMN Workforce Solutions, LLC Delaware4
- Advanced Medical Personnel Services, LLC Delaware4
- B4Health, LLC Maryland4
- Connetics Communications, LLC California4
- MSI Systems Corp. Pennsylvania4
- Medefis, Inc. Delaware4
- Nursefinders, LLC Texas4
- O’Grady-Peyton International (USA), Inc. Massachusetts4
- ShiftWise, Inc. Oregon4
- Spectrum Insurance Company, Inc. Hawaii4
- Stratus Video Costa Rica, S.A. Costa Rica4
The subsidiaries the company lists in Exhibit 21 of its annual report, as filed.
Timeline
- Aug 6, 20268-K Financial statements and exhibits46
- May 7, 20268-K Financial statements and exhibits47
- May 4, 20268-K Executive or director change; Shareholder vote48
- Feb 19, 20268-K Financial statements and exhibits49
- Feb 5, 20268-K Executive or director change50
- Jan 14, 20268-K Regulation FD disclosure51
- Dec 11, 20258-K Bylaws or fiscal year changed52
- Nov 6, 20258-K Results of operations53
- Oct 6, 20258-K Entered a material agreement; New debt or obligation; Other events54
- Sep 22, 20258-K Regulation FD disclosure55
- Sep 22, 20258-K Other events56
- Aug 7, 20258-K Results of operations57
- Nov 30, 2022New chief executive Caroline Grace becomes CEO14
- Jan 5, 2006New chief executive Susan R. Salka becomes CEO15
Calendar
Coming up
- Nov 5, 2026 · After the closeReports results for the quarter ending Sep/2026 A year earlier it reported $0.39 a share, on Nov 6, 2025.58
When it reported results
- Nov 6, 2025Reported quarterly or annual results53
- Aug 7, 2025Reported quarterly or annual results57
- May 8, 2025Reported quarterly or annual results59
- Feb 20, 2025Reported quarterly or annual results60
- Nov 7, 2024Reported quarterly or annual results61
- Oct 1, 2024Reported quarterly or annual results62
- Aug 8, 2024Reported quarterly or annual results63
- May 9, 2024Reported quarterly or annual results64
Upcoming dates from Nasdaq's calendar; past results from the company's 8-K filings (Item 2.02). The full markets calendar
Filings
293 filings to the SEC since October 2021: 5 annual reports, 15 quarterly reports, 48 major events, 171 insider forms, 23 large holders, 31 other. The latest 20:
- Sep 16, 20264 EDGAR
- Aug 13, 2026SCHEDULE 13G EDGAR
- Aug 7, 202610-Q EDGAR
- Aug 6, 20268-K EDGAR
- Jul 9, 20264/A EDGAR
- Jun 17, 20264 EDGAR
- Jun 15, 2026144 EDGAR
- May 8, 202610-Q EDGAR
- May 7, 20268-K EDGAR
- May 4, 20264 EDGAR
- May 4, 20264 EDGAR
- May 4, 20264 EDGAR
- May 4, 20264 EDGAR
- May 4, 20264 EDGAR
- May 4, 20264 EDGAR
- May 4, 20264 EDGAR
- May 4, 20264 EDGAR
- May 4, 20264 EDGAR
- May 4, 2026S-8 EDGAR
- May 4, 20268-K EDGAR
The 293 filings since October 2021 can be filtered by form type and year here when JavaScript is on.
Every filing from the last five years, summarized. The full record is on SEC EDGAR.
Insider trades
29 open-market trades by officers, directors and large owners since October 2021: 10 buys and 19 sales. Grants, option exercises and gifts are left out.
| Date | Who | Trade | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| Jun 15, 2026 | FOLETTA MARK GDirector | Sale | 3,681 | $31.07 | $114.4K | Form 4 |
| Nov 2, 2024 | Knudson Jeffrey RCFO | Sale | 2,461 | $36.90 | $90.8K | Form 4 |
| Mar 6, 2024 | Caballero Jorge A.Director | Buy | 2,000 | $56.80 | $113.6K | Form 4 |
| Mar 4, 2024 | Fontenot Teri G.Director | Buy | 1,732 | $57.64 | $99.8K | Form 4 |
| Feb 29, 2024 | HARRIS R JEFFREYDirector | Buy | 2,640 | $56.97 | $150.4K | Form 4 |
| Feb 29, 2024 | FOLETTA MARK GDirector | Buy | 500 | $56.90 | $28.4K | Form 4 |
| Feb 28, 2024 | Knudson Jeffrey RCFO | Buy | 6,951 | $57.75 | $401.4K | Form 4 |
| Feb 28, 2024 | Trent-Adams SylviaDirector | Buy | 175 | $57.02 | $10.0K | Form 4 |
| Feb 28, 2024 | WHEAT DOUGLAS DDirector | Buy | 2,620 | $56.87 | $149.0K | Form 4 |
| Feb 28, 2024 | Laughlin Whitney MChief Legal Officer | Buy | 863 | $57.74 | $49.8K | Form 4 |
| Feb 27, 2024 | Grace CarolineChief Executive Officer | Buy | 17,500 | $56.68 | $991.9K | Form 4 |
| Nov 28, 2023 | Hagan Mark ChristopherChief Information and Digital | Sale | 16,000 | $67.92 | $1.1M | Form 4 |
| Jun 14, 2023 | Jones Daphne EDirector | Sale | 1,000 | $109.57 | $109.6K | Form 4 |
| Apr 21, 2023 | FOLETTA MARK GDirector | Sale | 1,458 | $88.78 | $129.4K | Form 4 |
| Apr 11, 2023 | FOLETTA MARK GDirector | Sale | 6,042 | $84.35 | $509.6K | Form 4 |
| Jan 9, 2023 | Jackson Denise LChief Legal Officer | Sale | 4,001 | $110.76 | $443.2K | Form 4 |
| Jan 6, 2023 | Jackson Denise LChief Legal Officer | Sale | 1,002 | $109.30 | $109.5K | Form 4 |
| Nov 7, 2022 | WHEAT DOUGLAS DDirector | Sale | 4,900 | $118.00 | $578.2K | Form 4 |
| Aug 26, 2022 | Jackson Denise LChief Legal Officer | Sale | 6,330 | $107.09 | $677.9K | Form 4 |
| Jun 3, 2022 | Hagan Mark ChristopherChief Information and Digital | Sale | 1,400 | $97.53 | $136.5K | Form 4 |
All 29 trades can be filtered by person here when JavaScript is on.
From Forms 4 filed with the SEC.
Major holders
Investors who own more than 5% of the shares must tell the SEC: a 13D if they may seek to influence the company, a 13G if they hold passively.
- Morgan StanleySCHEDULE 13G, 1 filing Aug 13, 202665
- VANGUARD CAPITAL MANAGEMENT LLCSCHEDULE 13G, 1 filing Apr 29, 202666
- VANGUARD GROUP INCSCHEDULE 13G/A, 5 filings Feb 9, 2022 to Mar 26, 202667
- INTEGRATED CORE STRATEGIES (US) LLCSCHEDULE 13G/A, 2 filings Nov 10, 2025 to Feb 12, 202668
- FMR LLCSCHEDULE 13G/A, 7 filings Sep 10, 2024 to Nov 5, 202569
- BlackRockSCHEDULE 13G/A, 5 filings Jan 28, 2022 to Apr 30, 202570
- Boston PartnersSC 13G/A, 2 filings Feb 13, 2024 to Nov 14, 202471
Executive pay
What the company paid its top executives, from the summary compensation table in its proxy statement. Total pay includes salary, bonus, stock and option awards and other pay, as the company valued them.
| Year | Executive | Age | Salary | Total pay |
|---|---|---|---|---|
| 2025 | Cary GracePEO, President & CEO | $1.1M | $10.7M72 | |
| 2025 | Brian M. ScottPFO, CFO & COO | $630.0K | $3.4M72 | |
| 2025 | Mark C. HaganChief Information & Digital Officer | $550.0K | $2.6M72 | |
| 2025 | Whitney M. LaughlinChief Legal Officer & Corporate Secretary | $500.0K | $1.7M72 | |
| 2024 | Cary GracePEO, President & CEO | $1.1M | $9.6M72 | |
| 2024 | Mark C. HaganChief Information & Digital Officer | $550.0K | $4.2M72 | |
| 2024 | Brian M. ScottPFO, CFO & COO | $53.3K | $2.3M72 | |
| 2024 | Whitney M. LaughlinChief Legal Officer & Corporate Secretary | $442.3K | $2.1M72 | |
| 2023 | Cary GracePEO, President & CEO | $1.1M | $6.7M72 | |
| 2023 | Mark C. HaganChief Information & Digital Officer | $550.0K | $2.3M72 | |
| 2023 | Whitney M. LaughlinChief Legal Officer & Corporate Secretary | $361.9K | $814.5K72 |
Held by these funds
The largest holders among investment managers' 13F reports for the quarter ending Jun 30, 2026, the top 25 of 100. Change is in shares since the quarter before.
| Fund | Shares | Value | Share of the fund | Change |
|---|---|---|---|---|
| BlackRock, Inc. | 6,643,401 | $215.0M | 0.0% | +619,906 |
| Morgan Stanley | 2,282,597 | $73.9M | 0.0% | +941,922 |
| Vanguard Capital Management LLC | 1,719,045 | $55.6M | 0.0% | +41,619 |
| State Street Corp | 1,694,316 | $54.8M | 0.0% | +79,912 |
| Boston Partners | 1,674,561 | $54.2M | 0.0% | −463,827 |
| Arrowstreet Capital, Limited Partnership | 1,391,859 | $45.1M | 0.0% | −9,866 |
| Allianz Asset Management GmbH | 1,402,948 | $44.0M | 0.0% | +141,944 |
| Vanguard Portfolio Management LLC | 1,288,073 | $41.7M | 0.0% | +163,404 |
| Dimensional Fund Advisors LP | 1,283,381 | $41.5M | 0.0% | +542,172 |
| Two Sigma Investments, LP | 1,158,258 | $37.5M | 0.0% | −429,423 |
| Royce & Associates LP | 1,149,232 | $37.2M | 0.3% | +140,245 |
| Renaissance Technologies LLC | 1,096,521 | $35.5M | 0.0% | −279,820 |
| Ameriprise Financial Inc | 1,051,103 | $34.0M | 0.0% | +969,259 |
| Goldman Sachs Group Inc | 1,045,817 | $33.9M | 0.0% | +201,171 |
| Geode Capital Management, LLC | 1,006,303 | $32.6M | 0.0% | +82,193 |
| Charles Schwab Investment Management Inc | 740,471 | $24.0M | 0.0% | +45,119 |
| UBS Group AG | 646,553 | $20.9M | 0.0% | −221,423 |
| Tributary Capital Management, LLC | 601,198 | $19.5M | 1.6% | +2,701 |
| D. E. Shaw & Co., Inc. | 550,638 | $17.8M | 0.0% | −340,504 |
| Federated Hermes, Inc. | 525,781 | $17.0M | 0.0% | −40,389 |
| Bank Of America Corp /de/ | 516,710 | $16.7M | 0.0% | −70,659 |
| Aqr Capital Management LLC | 502,898 | $16.3M | 0.0% | +198,608 |
| Northern Trust Corp | 450,293 | $14.6M | 0.0% | +36,641 |
| Invesco Ltd. | 443,337 | $14.4M | 0.0% | +77,729 |
| Eversept Partners, LP | 428,531 | $13.9M | 0.8% | New |
13F reports cover disclosed long positions in U.S. stocks only.
Members of Congress who traded it
11 trades disclosed by members of Congress. “Vs S&P since” is the stock’s change since the trade minus the S&P 500’s.
| Date | Member | Trade | Amount | Vs S&P since | Filing |
|---|---|---|---|---|---|
| Sep 2, 2020 | Greg Gianforte, House | Buy | $1,001 - $15,000 | −143.6% | Report |
| Sep 2, 2020 | Greg Gianforte, House | Buy | $1,001 - $15,000 | −143.6% | Report |
| Sep 2, 2020 | Greg Gianforte, House | Buy | $1,001 - $15,000 | −143.6% | Report |
| Sep 2, 2020 | Greg Gianforte, House | Buy | $1,001 - $15,000 | −143.6% | Report |
| Sep 2, 2020 | Greg Gianforte, House | Buy | $1,001 - $15,000 | −143.6% | Report |
| Sep 2, 2020 | Greg Gianforte, House | Buy | $1,001 - $15,000 | −143.6% | Report |
| Sep 2, 2020 | Greg Gianforte, House | Buy | $1,001 - $15,000 | −143.6% | Report |
| Sep 2, 2020 | Greg Gianforte, House | Buy | $1,001 - $15,000 | −143.6% | Report |
| Sep 2, 2020 | Greg Gianforte, House | Buy | $1,001 - $15,000 | −143.6% | Report |
| Aug 31, 2020 | Greg Gianforte, House | Buy | $15,001 - $50,000 | −145.7% | Report |
| Jul 22, 2020 | Greg Gianforte, House | Buy | $50,001 - $100,000 | −160.2% | Report |
Members report amounts as ranges, not exact figures. Returns are price-only (no dividends).
SEC filer profile
How AMN HEALTHCARE SERVICES INC is registered with the Securities and Exchange Commission, from its EDGAR record and the cover page of its latest annual report.
- Name on EDGARAMN HEALTHCARE SERVICES INC1
- CIK0001142750
- Employer ID (EIN)06-15004765
- Filer statusLarge accelerated filer not an emerging growth company; not a smaller reporting company; not a shell company5
- Incorporated inDelaware5
- Fiscal year endsDecember 311
- Industry code (SIC)7363 Services-Help Supply Services1
- SEC reviewing officeOffice of Trade & Services, Division of Corporation Finance1
- Business address2999 Olympus Boulevard, Suite 500, Dallas, TX 750191
- Phone86687185191
- Shares outstanding38,729,991 as of Aug 4, 202612
- Public float$787.7M as of Jun 30, 20255
- AuditorKPMG LLP, San Diego, California PCAOB ID 185; it also attests to the company’s internal control over financial reporting5
- On EDGAR sinceJul 16, 20011
- Filings1,576 in all: 4 (862), 8-K (231), SC 13G/A (88), 10-Q (74), 3 (49), SC 13G (32), DEFA14A (30), DEF 14A (27)1
All 43 form types
10-K (25), 4/A (22), SC 13D/A (15), S-8 (14), SC TO-I/A (9), UPLOAD (9), ARS (8), CORRESP (8), SCHEDULE 13G/A (7), 8-K/A (6), 144 (5), S-1/A (5), 3/A (4), 424B3 (4), EFFECT (4), PRE 14A (4), SC 13D (4), SCHEDULE 13G (4), POS AM (3), S-3 (3), SC TO-I (3), DFAN14A (2), NO ACT (2), S-1 (2), 10-Q/A (1), 424B1 (1), 424B4 (1), 5 (1), 8-A12B (1), ARS/A (1), PREC14A (1), PREN14A (1), REGDEX (1), S-8 POS (1), SC TO-C (1)
- Latest filingsAnnual report (10-K) Feb 20, 2026
Quarterly report (10-Q) Aug 7, 2026
Proxy statement (DEF 14A) Mar 18, 2026
Latest 8-K (8-K) Aug 6, 2026
Securities registered for trading
| Class | Symbol | Exchange |
|---|---|---|
| Common Stock, $0.01 par value | AMN | New York Stock Exchange |
From the cover page of the 10-K filed Feb 20, 2026 (Section 12(b) of the Exchange Act).5
Risk factors and legal proceedings
The risks AMN HEALTHCARE SERVICES INC names in Item 1A of its 10-K filed Feb 20, 2026: 31 risks under these headings, as written.5
- The ability of our clients to increase the efficiency and effectiveness of their staffing management and recruiting efforts may affect the demand for our services that could negatively affect our business.
- Economic downturns, inflation and slow recoveries could result in less demand from clients and pricing pressure that could negatively impact our financial condition.
- If we are unable to anticipate and quickly respond to changing marketplace conditions, such as alternative modes of healthcare delivery, reimbursement and client needs, we may not remain competitive.
- Consolidation of healthcare delivery organizations could negatively affect pricing of our services and increase our concentration risk.
- Intermediary organizations may impede our ability to secure new and profitable contracts with our clients.
- The widespread outbreak of illness or other public health crisis could have an adverse effect on our business, financial condition and results of operations.
- The repeal of or changes to the Patient Protection and Affordable Care Act (“ACA”) may negatively affect the demand for our services.
- Since the healthcare regulatory landscape continues to evolve and because future legislative or administrative actions cannot be predicted, significant change or even prolonged uncertainty could negatively affect demand for our services, operating results and our overall business performance.
- Regulatory and Legal Risk Factors
- Investigations, claims and legal proceedings alleging medical malpractice, anti-competitive conduct, violations of employment, privacy and wage regulations and other theories of liability asserted against us could subject us to substantial liabilities.
- We are subject to federal and state healthcare industry regulation including conduct of operations, costs and payment for services and payment for referrals as well as laws regarding immigration and government contracting.
- The challenge to the classification of certain of our healthcare professionals as independent contractors could adversely affect our profitability.
The other 20 risks
- If we do not continue to recruit and retain sufficient quality healthcare professionals at reasonable costs, it could increase our operating costs and negatively affect our business and our profitability.
- Our inability to implement new infrastructure and technology systems and technology disruptions may adversely affect our operating results and ability to manage our business effectively.
- Our business could be harmed if we fail to further develop and evolve our current talent solutions technology offerings and capabilities.
- Disruption to or failures of our SaaS-based or technology-enabled services, or our inability to adequately protect our intellectual property rights with respect to such technologies, could reduce client satisfaction, harm our reputation and negatively affect our business.
- Security breaches and cybersecurity incidents could compromise our information and systems adversely affecting our business operations and reputation subject us to substantial liabilities.
- Use of AI may result in operational challenges or issues, liability, and reputational concerns.
- The inability to quickly and properly credential and match quality healthcare professionals with suitable placements may negatively affect demand for our services.
- Our operations may deteriorate if we are unable to continue to attract, develop and retain our sales and operations team members.
- We are increasingly dependent on third parties for the execution of certain critical functions.
- The loss of key officers and management personnel could adversely affect our business and operating results.
- Our inability to maintain our positive brand awareness and identity may adversely affect our results of operations.
- Our inability to consummate and effectively incorporate acquisitions into our business operations may adversely affect our long-term growth and our results of operations.
- Businesses we acquire may have liabilities or adverse operating issues which could harm our operating results.
- As we develop new services and clients, enter new lines of business, and focus more of our business on providing a full range of talent solutions, the demands on our business and our operating risks may increase.
- The use of social media platforms presents risks and challenges that can cause damage to our brand and reputation.
- We maintain a substantial amount of goodwill and intangible assets on our balance sheet that may decrease our earnings or increase our losses if we recognize an impairment to goodwill or intangible assets.
- Our indebtedness could adversely affect our ability to raise additional capital to fund our operations, limit our ability to react to changes in the economy or our industry, and expose us to interest rate risk to the extent of any variable rate debt.
- The terms of our debt instruments impose restrictions on us that may affect our ability to successfully operate our business.
- Variable rate indebtedness subjects us to interest rate risk, which could cause our debt service obligations to increase significantly.
- We have substantial insurance-related accruals and legal accruals on our balance sheet, and any significant adverse adjustments may decrease our earnings or increase our losses and negatively impact our cash flows.
Legal proceedings
Information with respect to this item may be found in “Item 8. Financial Statements and Supplementary Data—Notes to Consolidated Financial Statements—Note (13), Commitments and Contingencies,” which is incorporated herein by reference.
The opening of Item 3, Legal Proceedings.5
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2
- 3
- 4
- 5
- 6
- 7
- 8
- 9
- 10
- 11
- 12
- 13
- 14
- 15
- 16SEC EDGARSteven C. Francis, Chair
- 17SEC EDGARRalph Henderson, President
- 18
- 19
- 20SEC EDGARBary Bailey, Chief financial officer
- 21
- 22
- 23
- 24
- 25
- 26
- 27SEC EDGAREric P. Palmer, Board member
- 28SEC EDGARCelia P. Huber, Board member
- 29SEC EDGARJim Hinton, Board member
- 30SEC EDGARJorge A. Caballero, Board member
- 31SEC EDGARSylvia Trent-Adams, Board member
- 32SEC EDGARTeri G. Fontenot, Board member
- 33SEC EDGARDaphne E. Jones, Board member
- 34SEC EDGARMark G. Foletta, Board member
- 35SEC EDGARWyche H. Walton, Board member
- 36SEC EDGARMartha H. Marsh, Board member
- 37SEC EDGARHala G. Moddelmog, Board member
- 38SEC EDGARMichael M. E. Johns, Board member
- 39SEC EDGARAndrew M. Stern, Board member
- 40SEC EDGARDouglas D. Wheat, Board member
- 41SEC EDGARR. Jeffrey Harris, Board member
- 42SEC EDGARKenneth F. Yontz, Board member
- 43SEC EDGARPaul E. Weaver, Board member
- 44SEC EDGARWhitney M. Laughlin, General counsel
- 45SEC EDGARDenise L. Jackson, General counsel
- 46SEC EDGARFinancial statements and exhibits
- 47SEC EDGARFinancial statements and exhibits
- 48
- 49SEC EDGARFinancial statements and exhibits
- 50SEC EDGARExecutive or director change
- 51SEC EDGARRegulation FD disclosure
- 52SEC EDGARBylaws or fiscal year changed
- 53SEC EDGARResults of operations
- 54
- 55SEC EDGARRegulation FD disclosure
- 56SEC EDGAROther events
- 57SEC EDGARResults of operations
- 58NasdaqNasdaq calendar
- 59
- 60
- 61
- 62
- 63
- 64
- 65
- 66
- 67
- 68
- 69
- 70
- 71
- 72